中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2014年
22期
26-27
,共2页
心血管疾病%介入治疗%严重并发症%对策
心血管疾病%介入治療%嚴重併髮癥%對策
심혈관질병%개입치료%엄중병발증%대책
Cardiovascular disease%Interventional treatment%Serious complication%Countermeasures
目的:探讨分析心血管疾病介入治疗后的并发症及对策。方法心血管疾病介入治疗患者120例,分为心脏择期组45例、心脏急诊组31例和周围血管组44例,三组实施心血管介入治疗。结果120例心血管介入治疗后有36例患者出现严重并发症,发生率为30%,36例严重并发症中,心脏择期组严重并发症为11例,发生率为24.44%,心脏急诊组严重并发症为8例,发生率为25.8%,周围血管组严重并发症为17例,发生率为38.63%。严重并发症患者的具体表现有严重心律失常、造影剂休克过敏、穿刺点大血肿等。结论心血管疾病患者在接受介入治疗后产生的严重并发症种类较多,发生率最高的为严重心律失常、造影剂休克过敏、穿刺点大血肿等,应在治疗过程中给予及时的处理和预防,降低死亡率。
目的:探討分析心血管疾病介入治療後的併髮癥及對策。方法心血管疾病介入治療患者120例,分為心髒擇期組45例、心髒急診組31例和週圍血管組44例,三組實施心血管介入治療。結果120例心血管介入治療後有36例患者齣現嚴重併髮癥,髮生率為30%,36例嚴重併髮癥中,心髒擇期組嚴重併髮癥為11例,髮生率為24.44%,心髒急診組嚴重併髮癥為8例,髮生率為25.8%,週圍血管組嚴重併髮癥為17例,髮生率為38.63%。嚴重併髮癥患者的具體錶現有嚴重心律失常、造影劑休剋過敏、穿刺點大血腫等。結論心血管疾病患者在接受介入治療後產生的嚴重併髮癥種類較多,髮生率最高的為嚴重心律失常、造影劑休剋過敏、穿刺點大血腫等,應在治療過程中給予及時的處理和預防,降低死亡率。
목적:탐토분석심혈관질병개입치료후적병발증급대책。방법심혈관질병개입치료환자120례,분위심장택기조45례、심장급진조31례화주위혈관조44례,삼조실시심혈관개입치료。결과120례심혈관개입치료후유36례환자출현엄중병발증,발생솔위30%,36례엄중병발증중,심장택기조엄중병발증위11례,발생솔위24.44%,심장급진조엄중병발증위8례,발생솔위25.8%,주위혈관조엄중병발증위17례,발생솔위38.63%。엄중병발증환자적구체표현유엄중심률실상、조영제휴극과민、천자점대혈종등。결론심혈관질병환자재접수개입치료후산생적엄중병발증충류교다,발생솔최고적위엄중심률실상、조영제휴극과민、천자점대혈종등,응재치료과정중급여급시적처리화예방,강저사망솔。
Objective To investigate the countermeasures for serious complications after interventional treatment for cardiovascular. Methods Divided 120 cases of patients with cardiovascular disease treated with interventional therapy into three groups, elective cardiac group(n=45), cardiac emergency group(n=44), peripheral vascular group(n=44), all treated by cardiovascular interventional treatment. Results After cardiovascular interventional treatment, 36 cases of patients with serious complications, the incidence rate was 30%, 11 cases in elective cardiac group, accounting for 24.44%, 45 cases in cardiac emergency group, accounting for 25.8%, 17 cases in peripheral vascular group, accounting for 38.63%. Concrete manifestation in patients with serious complications were severe arrhythmia, contrast agent allergy, large hematoma puncture point. Conclusion Serious complications of cardiovascular interventional treatment are severe arrhythmia, contrast agent shock allergy, puncture site hematoma, timely treatment and prevention should be given in the treatment process to reduce the mortality rate.